MSD’s Keytruda closer to classical Hodgkin Lymphoma nod
admin 27th March 2017 Uncategorised 0MSD’s anti-PD-1 therapy Keytruda has taken a giant leap towards being approved in Europe for the treatment of classical Hodgkin Lymphoma (cHL).
More: MSD’s Keytruda closer to classical Hodgkin Lymphoma nod
Source: News